Last Seen Blogs
jiwoo-loves-cats
jiwoo is a precious cinnamon roll
lilybugmusings
Just Lilly Bugs Things
sadpieceofmoss
𖤐MOSSER𖤐
Text
Bone Density Test Market Insights, Key Players, Research Overview and Size Estimation To 2023
Bone Density Test Market Information: By Type (Central Dual-Energy X-Ray Absorptiometry (DXA), Radiographic Absorptiometry), Indication (Osteoporosis, Hyperthyroidism,), Device (Central DEXA Scan Machine), End User (Hospitals) - Global Forecast Till 2027
Bone Density Test Market Highlights
Bone density test is a quick way to measure the bone density of the spine, hip, and wrist. Market Research Future (MRFR) reports, rising number of cases of osteoporosis, and osteopenia and a growing concern for a healthier future are indicators expected to steer the growth of the bone density test market. It can expand at a CAGR of 7.2% during the forecast period (2017-2023).
Drivers and Restraints:
With better medical facilities, there is now a rise in geriatric population and so are the cases of diseases, such as osteoporosis, and osteopenia. Osteoporosis often called the ‘silent disease’ as it shows no many symptoms. In this case, bones start to get weak with aging. According to the International Osteoporosis Foundation (IOF), osteoporosis can affect nearly 8.9 million annually. A sedentary lifestyle is also a major concern. But people are becoming more health-conscious, and this is expected to drive the global bone density test market forward.
As an add-on, governments and non-profit organizations are also showing interest in spreading awareness regarding diseases, such asosteoporosis, and osteopenia. This can also play a driving factor in the advancement of the global bone density test market.
However, expensive nature of these tests and limited reimbursement policy options can deter the global growth rate of bone density test market.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/4766
Segmentation:
The global bone density test market is segmented based on type, indication, devices, and end-user.
Type-based global bone density test market has segments, such as central dual-energy x-ray absorptiometry (DXA), peripheral tests, radiographic absorptiometry, and others. Central dual-energy x-ray absorptiometry is simple, quick and non-invasive offering the most accurate diagnosis of the disease. The peripheraltest segment has sub-segments, such as peripheral dual-energy X-ray absorptiometry (pDXA), quantitative ultrasound (QUS), and peripheral quantitative computed tomography (pQCT).
By indication, the market is segmented into osteoporosis, osteopenia, hyperthyroidism, hyperparathyroidism, and others. Osteoporosis or the ‘porous bone’ is most common in women and causes approx. 8.9 million fractures annually. Hyperparathyroidism is quite common in people aged over 50. Hyperthyroidism threatens mostly neo-natal or newborn babies.
Based on test-devices the market is segmented into central DEXA scan machine and handheld devices. The central DEXA scan machine is the popular choice owing to its accuracy.
Major end-users include hospitals, clinics, diagnostic centers, and others.
Regional Analysis:
Regions covered in the bone density market report include the Americas, Europe, Asia Pacific, and the Middle East & Africa (MEA).
A rise in bone disease-related patients and increasing demand for hand-held bone test machines have helped the U.S. to secure the top position in the global bone density test market. People with bone density problems are much higher in this regions as compared to others. The market has grown owing to a change in lifestyle, focus on fitness and exercise, and burgeoning medical industry.
Europe is not lagging as far as the last few years have witnessed a rise in osteoporosis patients. However, the changing demographics could affect the prevalence of the disease.
Asia Pacific is expected to grow at a rapid rate during the forecast period as awareness regarding bone-related diseases is increasing with the passing years. Japan holds the most significant share in the bone density test market. The region is now spending more on healthcare and has boosted the demand for medical devices. Asia Pacific region is also becoming a hub for global patients. For instance, in 2015, Indian hospitals alone had 460,000 international patients for various treatments. Rise in medical tourism and demand for affordable surgeries can propel market demand in the coming years.
However, the Middle East & Africa are expecting a steady rise due to low awareness regarding bone density and the demand for such tests is low compared to other regions.
Market Analysis:
The global bone density test market is highly competitive with the presence of reputed names along with local players in many countries. The factors driving the global market are product precision, product cost, measurement speed, radiation dose, and product dependability and versatility.
Key players influencing the global bone density test market are General Electric Company (U.S.), Hologic Inc. (U.S), Beam Med Ltd. (Israel), Swissray (U.S.), Osteosys Corp (South Korea), DMS Imaging (France), Medonica Co. LLTb (South Korea), Osteometer Meditech Inc. (U.S), and Lone Oak Medical Technologies, LLC (U.S.).
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/bone-density-test-market-4766
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Global Biosensor Market Future Insights, Share Value, COVID-19 Impact and Emerging Trends By 2023
Global Biosensor Market Research Report: Information By Technology (Electrochemical Biosensors, Optical Biosensors, Thermal Biosensors and Piezoelectric Biosensors), By End User (Point of Care, Home Diagnostics, Research Laboratories, Food Industry and Security and Biodefense), By Application (Medical Testing, Food Toxicity, Industrial Process, Environmental and Agricultural Testing) - Forecast till 2027
Biosensor Market Highlights
Biosensors are analytical devices composed of biological detecting elements like sensor system and a transducer for providing analytical information. To recognize the function and structure of different molecules, these devices help convert the biological response into an electrical response. When compared with any other existing diagnostic devices, the biosensors are much more advanced in terms of selectivity and sensitivity. Its effective capability of prompt detection and measuring wide spectrum across different applications make it a highly beneficial device. Its applications stretch into the field of healthcare, environmental monitoring, industrial process control, military application, agriculture, and veterinary monitoring. In the agricultural and food industries, its use involves the checking of ecological pollution control. According to the in-depth research conducted by Market Research Future (MRFR), the global biosensor market is expected to grow at a moderate pace due to a number of factors. Factors like the increasing demand of Point-of-Care Testing (POCT), wide-spread prevalence of the diabetes and chronic and lifestyle-based diseases, rise in the geriatric population, and expanding applications of biosensors in various sectors are all contributing to the overall growth of the market. The market is forecasted to grow at a rate of 9.6% during the review period between 2014 to 2020.
Market Segmentation
The global biosensor market segmentation is done on the basis of technology, application, and end-user.
By technology, the market divides into thermal biosensors, electrochemical biosensors, piezoelectric biosensors, optical biosensors, and others. The piezoelectric biosensors hold the largest share in this market segment.
By application, the market includes industrial process, agricultural testing, medical testing, environmental market, into food toxicity, and others.
By end-user, the market comprises research laboratories, security and biodefense, food industry, point of care, home diagnostics, and others. The security and biodefence segment is the biggest market share holder because of the increasing biological threats and the proliferating need to protect them.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/1228
Regional Analysis
The biosensor market is geographically segmented into the Americas, Asia-Pacific, Europe, and the Middle East & Africa.
The Americas region is the largest market for biosensors in the world. Out of the two American continents, North America accounts for the largest market share. The North American region is further narrowed down into the US, which is most prominent regional country in the region. The region is increasingly willing to adopt new and advancing healthcare technologies and boasts high technological capability. Also, the presence of various leading market players and a surging diabetic population is also expected to accelerate the demand for the biosensor market.
The European regional market is also growing at a continuous pace and is gradually catching up to the North American market. The presence of a huge geriatric population therein is driving the regional market in Europe.
The Asia-Pacific regional market is expected to grow with the highest CAGR due to the potential the region holds. The region holds a high percentage of emerging markets and there lies an increasing focus on the provision of high-quality healthcare. The APAC market is expected to grow at an exponential pace due to the overall increase in demand for biosensor technology.
Competitive Landscape
The global biosensor market holds a number of key players including Nova Biomedical Corporation, F. Hoffmann-La Roche Ltd., Tia Doc Technology Corporation, Life Sensors Inc., Medtronic, Inc., Siemens Healthcare, Abbott Laboratories Inc., I-SENCE Inc., Johnson & Johnson, and Bayer Healthcare.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/biosensor-market-1228
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Stroke Disorder & Treatment Market Insights, Growth Outlook, Segmentation and Investment | Forecast to 2027
Global Stroke Disorder & Treatment market Information, by types (ischemic stroke, hemorrhagic strokes) by medicine (an-ticoagulants, anti-hypertensive) by treatment (tissue plasminogen activator (TPA), endovascular procedures)- Forecast to 2027
Stroke Disorder & Treatment market Highlights
The global stroke disorder treatment market has encountered notable growth in the past few years. The primary reason for this expansion is the increased ubiquity of chronic diseases in the general population. In recent times, the demand for stroke disorder treatment methodologies has billowed. This is why Market Research Future a well-known market research company decided to release a report titled ‘Stroke Disorder Treatment’. The report confirms that stroke disorder treatment market will gain a lot of traction during the forecast period of 2017-2022.
An individual experiences a stroke when there is a blockage or bleeding in the cerebrovascular system. It can lead to both a neurological deficiency that continues beyond 24 hours or it may even cause death.
The stroke disorder treatment market seems to be in great shape at present and the imminent years will bring with themselves many positive developments. This fact is backed by the assessed CAGR and revenue return figures. Experts suggest that this market will experience a tremendous influx of new players which will lead to progression.
Currently, millions of people across the world suffer from high blood pressure issues. This fact has been identified as one of the major growth propellers for this market. Apart from this, additional factors like increasing levels of alcoholism and the higher number of people suffering from diabetes and cardiovascular diseases further propel the market towards growth.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/1651
Market Segmentation
The research report by Market Research Future titled ‘Stroke Disorder Treatment Market’ offers a comprehensive analysis of all the segments of this market. Here are some of the main pointers from the segmental analysis section of the report.
By treatment – Surgical treatment, carotid endarterectomy, endovascular procedures and tissue plasminogen activator (TPA).
By type – Hemorrhagic strokes and of ischemic stroke.
By medicine – Anti-hypersensitive and anticoagulants/antiplatelet.
Comprehensive Geographical Analysis
The stroke disorder treatment market has successfully established itself on the world map. Over the years it has expanded to various regions of the globe. Some of the main regions where its presence can be predominantly observed are North America, Asia Pacific, Europe and Rest of the World.
After carrying out an in-depth evaluation of all the regional trends of the above-mentioned areas, the research report by Market Research Future discovered that it was North America that lead the market from a regional viewpoint. This market is anticipated to tread forward at an impressive CAGR during the projection span. The growth of this region could be attributed to the rapid advancements in stroke treatment in this region.
Europe sums up for the second largest market for stroke disorder treatment market. During the forecast period, this market is anticipated to move forward at a rapid pace. Asia Pacific is alsopresumed to witness significant growth by the end of the forecast period.
Industry News
Last year in the month of June, Novartis AG a popular organization associated with stroke disorder treatment market announced that it will be starting trials on a drug called Illaris. The company claims that this drug has the ability to prevent strokes and heart attacks by reducing inflammation in the person’s body.
Market Players & Key Strategies
The stroke disorder treatment market is highly competitive but it also proficient at the same time. Which is why this market has numerous stakeholders to its name. However, some of the most successful in this market can be listed as Pfizer (U.S.), Daiichi Sankyo (Japan), Bayer Pharma AG (Germany), and Novartis AG (Switzerland).
These players need to constantly update themselves to the latest industry trends to ensure that they are ahead in the competitive arena. Apart from that they also tend to employ certain growth strategies like mergers, acquisitions and investment in research and development activities.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/stroke-disorder-treatment-market-1651
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
AkashAnand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Stem Cell Manufacturing Market Profile, Sales, Cost, Dynamics and Capacity To 2027
Stem Cell Manufacturing Market: Information by Application (Therapy & Research & Cell), Product (Stem Cell Lines and Instruments, Consumables & Culture Media), End User (Pharmaceutical/Biotechnology Companies & CRO), & Region - Global Forecast till 2027
Stem Cell Manufacturing Market Highlights
The global stem cell manufacturing market is eyeing for a healthy growth at an impressive 6.6% CAGR over the estimated years (2018-2023). Stem cell manufacturing simply put is used for extracting cells from the bone marrow or peripheral blood cells. The cells which are extracted are generally cultured in a dish containing nutrient media. In fact, stem cells are isolated from umbilical cord blood, placenta, amniotic sac & fluid, adipose tissue and menstrual blood.
There are plentiful factors that is boosting the growth of the stem cell manufacturing market. These factors as per the Market Research Future (MRFR) report include increasing funding and public-private investments in research that is stem cell-based, growing public awareness about stem cell products therapeutic potency, creation of latest genomic analysis methods for quality control at the time of stem cell manufacturing, advancements in technology in manufacturing and preservation of stem cell, and evolving regulatory frameworks exclusively for stem cell therapeutics. On the contrary, stringent regulations on stem cell manufacturing coupled with high expenditure of research and manufacturing processes are factors that may impede stem cell manufacturing market growth over the estimated years.
Market Segmentation
MRFR report provides an extensive segmental analysis of the stem cell manufacturing market on the basis of application, product and end-user.
By product, it is segmented into culture media, consumables, stem cell lines and instruments. The stem cell lines segment is further segmented into mesenchymal stem cells (MSCs), embryonic stem cell (ESC), induced pluripotent stem cell (iPSC), hematopoietic stem cells (HSCs) and others. Among these, culture media will have the largest share in the market over the estimated years.
By application, it is segmented into therapy, research, target identification and cell & tissue banking. The therapy segment is further divided into autologous and allogeneic. Among these, the cell & tissue banking segment will dominate the market over the estimated years followed by research that is predicted to grow at the fastest pace.
By end-user, it is segmented into pharmaceutical & biotechnology companies, stem cell banks, hospitals and others. Among these, pharmaceutical & biotech companies will head the market over the estimated years.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/6942
Regional Analysis
By region, the stem cell manufacturing market is segmented into North America, Europe, Asia Pacific and Middle East and Africa. Among these, North America is anticipated to govern the market over the estimated years. This is owing to increasing investments being made in research and development related to healthcare, therapeutic potency of the stem cells and growing public-private funding. The stem cell manufacturing market in the European region will have the second major share due to in-depth research on stem cell in this region. In the APAC region the stem cell manufacturing market will grow at the fastest pace on account of growing awareness regarding the therapeutic uses associated to stem cells and expanding biotechnology industry in this region. In the Middle East and Africa, the stem cell manufacturing market will accrue small share over the estimated years yet its growth however is prognosticated to be driven via the growing healthcare infrastructure.
Key Players
Merck KGaA,Thermo Fisher Scientific, BD,Bristol-Myers Squibb Company, AbbVie Inc.,Lonza,Bio-Rad Laboratories, Inc.,Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd.,American CryoStem Corporation,STEMCELL Technologies Inc,Takara Bio Inc.,MiltenyiBiotec, and FUJIFILM Cellular Dynamics, Inc. (FCDI) are the leading players profiled in the stem cell manufacturing market.
April 2019- Researchers at the Institute for Molecular Engineering have created a “lab-on-a-chip” which will help people to understand as to how single stem cells will react to various molecules and environments. This chip can help in examining thousands of single live cells within a weeklong period and also perform experiments which in case of a laboratory will take over 1 million steps. The credit-card sized device along with saving money and time will also provide a new glimpse regarding how an individual stem cell will react to various environments and molecules. This microfluidic device can sort, culture and image individual cells in a high-throughput and automated way.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/stem-cell-manufacturing-market-6942
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
AkashAnand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Optical Imaging Market Size, Trends, Growth and Insights Till 2027
Optical Imaging Market Information: By Products (Imaging Systems), by Techniques (Photo Acoustic Imaging), by Therapeutic Area (Neurology and Oncology), by Application (Pathological Imaging), And End-Users (Hospitals & Clinics) – Global Forecast Till 2027
Optical Imaging Market Highlights
The global optical imaging market size could be valued at USD 1.92 Billion in 2023, estimates Market Research Future (MRFR). The market is expected to achieve a CAGR of 10% during the forecast period (2018-2023).
Market Drivers and Key Barriers
Optical imagingrefers to a technology that holds great potential to improve the mode of treatment, disease diagnosis, and preventionin the hospital operating room. This technology offers a host of benefits compared to radiological imaging techniques. Optical imaging technique makes use of non-ionizing radiation and reduces the patient’s radiation exposure, which gives way to numerous studies over time. It also helps differentiate soft tissues from native soft tissues or the tissues that posses exogenous or endogenous contrast media using various photon absorption profiles at different wavelengths. Opticalimaging is a highly responsive imaging technique which can be used by easily combining it with other imaging techniques.
Pharmaceutical and biomedical industries make heavy demand for radiation-free imaging techniques, which accelerates the popularity of optical imaging. Surging prevalence of neurological as well as ophthalmological disorders among the worldwide population could accelerate demand for imaging diagnosis, thereby elevating market growth. Technological advancement coupled with increasing government support that benefits the healthcare industry paves the way for several growth opportunities.
Some other growth-inducing factors driving market growth include quick adoption rates of technically advanced devices, highly-developed research infrastructure, and growing number of skilled professionals. Technological advancement has led to complete transformation of medical science, where optical imaging stands as the most affected aspect. This has revolutionized the healthcare industry by increasing the ability to detect a higher number of diseases.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/6172
Market Segmentation
The worldwide market for optical imaging has been segmented on the basis of products, techniques, therapeutic area, application, and end-user.
With respect to the type of product, the market comprises imaging systems, software, lenses, illumination systems, cameras, and others. Imaging systems can be sub-segmented into optical imaging systems and spectral imaging systems.
Technique-wise, the market covers optical coherence tomography (OCT), photoacoustic imaging, diffused optical tomography, hyperspectral imaging, near-infrared spectroscopy, and super-resolution microscopy.
Depending on the therapeutic area, the market covers oncology, ophthalmology, neurology, cardiology, dermatology, dentistry, and others.
Considering the application, the market caters to pre-clinical and clinical research, pathological imaging, and intraoperative imaging.
The end-users in the market include hospitals and clinics, diagnostic imaging centers, pharmaceutical &biotechnology companies, and research laboratories.
Regional Insight
Based on the geographical distribution, the market for optical imaging has been studied in the primary regions of Europe, the Americas, Middle East, and Africa and Asia Pacific.
The Americas has been identified as the largest market for optical imaging. Rising prevalence of neurological, ophthalmic,and cardiovasculardisorders among the geriatric population triggers market growth in the region. Moreover, a boost in the number of government initiatives along with funding for research within the medical devices sector stimulates market growth. Mounting demand for accurate diagnosis, high awareness regarding the adverse effects of radiation imaging, and presence of highly regarded pharmaceutical companies work in favor of the market. Also, vast patient pool in the region is expected to augment market demand in the years to come.
Europe stands as the second leading market for optical imaging. The robust share is the result of existence of advanced treatment facilities, high healthcare expenditure, and well-developed healthcare infrastructure. The flourishing medical device industry backed by the efforts of prominent players adds to the market strength. Plus, rising knowledge with regard to the benefits of optical imaging compared to radiation imaging spurs the market growth in the region.
Asia Pacific could expand at the fastest rate, holding the most promising growth prospects. A 2014 report by the department of neurology reveals that among the present population of 1.27 billion, close to 30 million people are afflicted with neurological disorders only in India. Therefore, the huge patient pool combined with the fast rate at the healthcare technology is catching up, the regional market is bound to note excellent gains in the near future. The region also benefits from various government initiatives that help improve healthcare quality and the availability of favorable insurance policies. Apart from this, the lower cost of clinical trials and several research companies striving to set up their regional headquarters as well as manufacturing plants in China, Singapore, Korea, Australia,and Japan could mark an optimistic market outlook in the subsequent years.
Middle East & Africa could showcase poor growth in the global market. The factors holding back the market include limited access and availability of treatment facilities and lack of awareness. In the Middle East, Saudi Arabia and the United Arab Emirates (UAE) account for the substantial share in response to the steadily expanding healthcare industry and increasing number of specialty care centers. Overall, the regional market could demonstrate consistent growth soon owing to rising number of government initiatives aimed at enhancing the quality of healthcare.
Renowned Companies
Some of the renowned companies shaping the worldwide optical imaging market are Bioptigen, Inc., Agfa-Gevaert N.V., Perkinelmer, Inc., Carl Zeiss Meditec AG, St. Jude Medical, Inc., Topcon Corporation, Heidelberg Engineering, Inc., Canon Inc., Koninklijke Philips N.V., among others.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/optical-imaging-market-6172
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
AkashAnand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Electron Microscope Market Segmentation, Applications, Dynamics and Overview By 2027
Electron Microscope Market Research Report by Type (Transmission Electron Microscope (TEM), Scanning Electron Microscope (SEM), and Others), Application (Nanotechnology, Material Sciences, Semiconductors, and Others), and Region (North America, Europe, APAC, RoW)-Global Forecast to 2027
Electron Microscope Market Highlights
The global electron microscope market is presumed to demonstrate 7.9% CAGR during the forecast period (2017-2023) owing to the technological advancements, asserts Market Research Future (MRFR).Electron microscope is referred to as the type of microscope which uses beam of electrons in order to create an image of the specimen. Electron microscope possesses a greater resolving power than a light microscope and is capable of much higher magnification, thereby allowing it to view smaller objects in finer details. Visualization and magnification devices are an important part of the microscopy industry and are being extensively used in sectors like agriculture, polymer industry, atomic studies, and nanotechnology.
Drivers and Restraints Impacting the Market
With high demand for technologically advanced magnification devices and diverse applications, the global electron microscope market is presumed to flourish during the assessment period. Technological advancements such as effective sample preparation techniques and faster processing are anticipated to trigger the demand for electron microscope in the coming years. Integration of such advancements with display modalities in order to enhance high definition and 3D images are likely to contribute to the market growth across the globe. Moreover, growing life science applications along with research and development expenditure, and high level of study regarding research are presumed to drive the market.
On the flip side, such microscopes require specimen to be thin enough for the electrons to pass through. Difficulties in the preparation of such specimens are considered to impede the market growth in the coming years.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/6656
Global Electron Microscope Market: Segmental Analysis
The global electron microscope market has been segmentedon the basis of type, application, and region.
By mode of type, the global electron microscope market has been segmented into scanning electron microscope (SEM), transmission electron microscope (TEM),and others. Among these, the scanning electron microscope (SEM) segment is presumed to exhibit the fastest CAGR during the assessment period. They are very useful to observe the size and shape of the specimen as they offer a 3D view. With increasing application in the material sciences and chemistry, the SEM segment is expected to boost in the coming years.
By mode of application, the global electron microscope market has been segmented intomaterial sciences, nanotechnology,semiconductors, and others. Among these, electron microscopes are highly used in the field of semiconductors. It is extensively used in the field of analyzing circuit failure and circuit edit.
Regional Insights
Geographically, the global electron microscope market spans across regions namely, Europe, America, Asia Pacific, and the Rest-of-the-World.
Among all the regions, the American region is estimated to be the largest region owing to the availability of advanced medical facilities and the presence of major market players in North America. North America is considered to be the largest market in this region due to higher health coverage and high adoption of advanced technology.
Europe holds a significant market share owing to the high density of population and availability of advanced medical facilities in this region. The Asia Pacific region, on the other hand, has emerged as the fastest growing market across the globe owing to the demand for improved medical facilities. Major markets in this region comprise India, Japan, China, and Australia. With the rapidly developing healthcare infrastructure and booming medical tourism industry, the market is likely to flourish. Moreover, the flourishing R&D industry is likely to trigger the demand for electron microscope.
Industry Updates
October 31, 2018: A Titan Krios cryo-electron microscopewas inaugurated on November 2017 at the European Synchrotron, France. Data collected demonstrates the activation cycle of a serotonin receptor which is targeted by the medication against radiotherapy and chemotherapy-induced nausea.
Competitive Dashboard
The prominent players operating the global electron microscope market are Phenom-World,Nikon Metrology Inc., Hirox Ltd., Hitachi High-Technologies Corporation, KEYENCE CORPORATION, Carl Zeiss International, Thermo Fisher Scientific,Agilent Technologies, Leica Microsystems, Bruker Corporation, Nanoscience Instruments Inc., JEOL Ltd., Olympus Corporation, and Merck KGaA, Angstrom Advanced Inc.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/electron-microscope-market-6656
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
AkashAnand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Dental Prosthetics Market Demand, Cost, Key Players, Sales and Profit By 2027
Global Dental Prosthetics Market: Information By Type (Denture, Crown, Bridges, Veneer, Abutment, Inlays), By Type of Material (Porcelain-Fused-to-Metal (PFM), Metal, All-Ceramic, Others) and By End User (Dental Hospitals & Clinics, Dental Research Laboratories) - Forecast till 2027
Dental Prosthetics Market Highlights
The global dental prosthetics market is presumed to expand at 5.5 % CAGR during the assessment period (2016-2023) owing to the growing geriatric population, asserts Market Research Future (MRFR). Also known as Prosthodontics, dental prosthetics are generally used to improve deficient or damaged teeth and also improves function and appearance of the teeth. Dental prosthetics deal with temporary or permanent replacement of missing teeth. Screws or dental adhesives are used in fixing dental prosthesis to teeth.
Drivers and Constraints Impacting the Market
The global dental prosthetics market is expanding moderately owing to several factors such as growing awareness of oral health and rising geriatric population. Improved processes due to extensive research in the field are highly encouraging people to adopt dental prosthetics, thereby fostering the market growth. Also, escalating market for cosmetic dentistry treatment supports dental prosthetics market to augment worldwide. Moreover, social and cultural factors like influence of the film and media industry coupled with the peer pressure for beauty and appearance are considered to fuel the market growth during the review period.
On the flip side, inadequate reimbursements for dental prosthetics is likely to retard the market growth globally in the coming years. Moreover, entry of new market players is creating high level of disparity in the cost of dental prosthetics, as local vendors offer such products at much lower prices. This is likely to impede the market growth during the assessment period.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/2905
Global Dental Prosthetics Market: Segmental Analysis
The global dental prosthetics market has been segmented on the basis of type, material, end-users, and region.
By mode of type, the global dental prosthetics market has been segmented into inlays, crown, veneer, abutment, bridges, and denture. Among these, the demand for bridges and crowns are likely to remain high during the review period. They are most commonly used as they are easy to use and offer high degree of aesthetics.
By mode of material, the global dental prosthetics market has been segmented into metal, all ceramic, porcelain-fused-to-metal, and others.
By mode of end-users, the global dental prosthetics market has been segmented into dental research laboratories, dental hospitals & clinics market, and others.
Regional Insights
Geographically, the global dental prosthetics market span across North America, Europe, Asia Pacific, and the Middle East and Africa.
Among all the regions, the North American region is presumed to hold the largest market share with 38.4 % in 2014. The growth in this region is attributed to growing market in the U.S. which is heading with high expenditure on healthcare. Also, the high demand for dental prosthetics stimulates the market growth in this region.
Europe is estimated to account for the second largest market during the review period owing to the rising per capita healthcare expenditure backed by resurging economy coupled with proliferation of healthcare penetration in this region. Countries like Germany, U.K., and Italy support the market growth to a large extent.
The Asia Pacific region prolife rating rapidly and is likely to emerge as one of the profitable markets globally. Growing markets in China and India backed by burgeoning medical treatment market, and vast population in the region stimulates the market growth. Countries such as Vietnam, Thailand, and Malaysia are presumed to contribute to the growth of the market.
Industry News
October 04, 2018: GDC Holdings, Inc., which owns National Dentex Labs has announced that it has acquired Trident Dental Laboratories which is headquartered in Hawthorne. While NDX and Trident will continue to operate independently, their combined offerings will offer superior restorative dentistry options in the dental lab industry.
Competitive Dashboard
The major players operating the global market are Institut Straumann AG (Switzerland), Henry Schein Inc. (US), Osstem Prosthetics (South Korea), Ivoclar Vivadent AG (Liechtenstein), DENTSPLY Sirona (US), Nobel Biocare (US), 3M (US), CAMLOG Biotechnologies AG (Switzerland), Zimmer Biomet (US), and Planmeca OY (Finland).
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/dental-prosthetics-market-2905
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Concussions Market to Register a CAGR of 3.22% Globally till 2023
Concussions Market: Information by Treatment (Diagnosis and Treatment) by End User (Hospitals and Clinics, Diagnostic Centers and Payers) & Region - Global Forecast till 2027
Concussions Market Highlights
The global concussion market is predicted to touch USD 1,060.4 million at a 3.22% CAGR over the forecast period (2019-2023), as per the latest Market Research Future (MRFR) report. Concussion is the least serious and also the most common form of traumatic brain injury. It is graded as grade 1 (mild), grade 2 (moderate), and grade 3 (severe), resting on such factors as amnesia, loss of equilibrium, and loss of consciousness. Concussions are generally caused by a blow on the head. Shaking the upper body and the head violently can also cause concussions. It can also result from a jolt or blow to the head or a hit to the body, which makes the brain and the head to move back and forth rapidly. Such a sudden movement may cause the brain in bouncing around or twisting in the skull, thereby creating chemical changes in the brain and at times stretching or damaging brain cells.
Various factors are propelling the concussions market growth. These factors, as stated by the MRFR report, include growing geriatric population, ongoing product development and approval, and rising incidence of mild traumatic brain injuries.
On the contrary, the shortage of skilled professionals and the stringent regulatory framework are factors that may impede the concussions market growth over the forecast period.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/5724
Market Segmentation
The Market Research Future report provides a wide segmental analysis of the concussions market based on treatment and end user.
Based on treatment, the concussions market is segmented into treatment and diagnosis.
Based on end user, the concussions market is segmented into payers, diagnostic centers, and hospitals and clinics. Of these, the diagnostic centers segment will have the largest share in the market over the forecast period.
Regional Analysis
Based on the region, the concussions market report covers growth opportunities and the latest trends across the Asia Pacific (APAC), Europe, the Americas, and the Middle East and Africa (MEA). Of these, the Americas will have the lion’s share in the market over the forecast period. This is owing to the increasing cases of concussions. Besides, the rising awareness created by various private firms and government organizations is also propelling market growth in this region.
The concussions market in Europe is predicted to have the second-largest share in the market over the forecast period. This is owing to the growing incidences of concussions in this region.
The concussions market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is owing to increasing disposable income and the developing healthcare infrastructure. Moreover, increase in the improved healthcare infrastructure, an increase in the R&D development center setups, and an increase in traumatic brain injuries are also pushing market growth in this region. Japan is the key contributor in this region.
The concussions market in the MEA is predicted to have a steady growth over the forecast period. This is owing to healthcare affordability and limited access among the population. Growing awareness of health as well as the availability of new diagnostic methods and treatment, and the rising number of traumatic brain injuries in this region is boosting the market growth.
Key Players
Leading players profiled in the concussions market report include Sanofi SA, Novartis AG, Mylan NV, Pfizer, Inc., Lupin, Zydus Cadila, Sun Pharmaceutical Industries Ltd, Integra LifeSciences Corporation, Medtronic PLC, and Teva Pharmaceutical Industries Ltd, among others. Key players are acquiring various strategies to strengthen their position and create a niche in the market. These include mergers and acquisitions, partnerships, research and development activities, product innovations, and more.
July 2019: Rutgers has joined hands with Big Ten Study for reducing concussions. This will offer an invaluable opening for ongoing collaboration between administrators, researchers, athletic trainers, and physicians to understand who has a higher risk of injury, as well as how the risk can be reduced. Through this collaboration, they will be at the forefront to understand what surges risks of concussions and cutting down the prevalence and risk of concussion.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/concussions-market-5724
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
AkashAnand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Companion Animal Healthcare Market To Project 9.6% CAGR By 2023
Companion Animal Healthcare Market Information, By Product (Feed Additives, Pharmaceuticals and Vaccines), By Diagnostic Tests (Diagnostic Imaging, Immunodiagnostic Tests, Molecular Diagnostics, others), By End Users - Global Forecast till 2027
Companion Animal Healthcare Market Highlights
Market Research Future (MRFR)’s latest study has revealed that the global companion animal healthcare market is poised to proliferate rapidly at a CAGR of 9.6% during the forecast period 2017 to 2023. The market is set to grow from USD 14 Bn in 2016 to USD 20 Bn in 2023. The growing trend of pet adoption is likely to fuel demand in the companion animal healthcare market as it provides a sense of belongingness and responsibility to the people. The exponential geriatric population has accelerated the rate of pet adoption in the recent times. The trend is anticipated to perpetuate across the assessment period.
An increase in the expenditure on companion animals coupled with advancements in medicines and vaccinations have fueled the demand in the market. The market resonates strong growth opportunities presently, and the rising per capita income of the population is likely to have a positive influence on the expansion of the companion animal healthcare market.
The increasing inclination of the pet owners towards a healthy lifestyle of their companions is projected to catapult the companion animal healthcare market on an upward trajectory. The growing number of nuclear families has paved the way for a rise in pet adoption and expenditure among the middle-class families, which is prognosticated to favor the growth of the market over the next couple of years.
Market Segmentation:
By product, the global Companion animal healthcare market has been segmented into feed additives, pharmaceuticals, and vaccines.
By diagnostic tests, the companion animal healthcare market is segmented into diagnostic imaging, immunodiagnostic tests, molecular diagnostics, and other tests.
By end-users, the global companion animal healthcare market has been segmented into veterinary hospitals, veterinary clinics, and home care.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/1168
Regional Outlook:
By region, the global companion healthcare animal market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas is the largest market for companion animal healthcare and is forecasted to exhibit significant growth over the assessment period. The wide range of product offerings for animal healthcare coupled with a great emphasis on the pet health is set to aid market proliferation in the region.
Europe is the second largest regional companion healthcare animal market. The factors projected to favor the market expansion during the forecast period include tax benefits from governments, rising pet ownership, etc.
The increasing awareness about the animal cruelty is set to provide an impetus to the growth of the Asia Pacific market. Meanwhile, the Middle East & Africa is expected to register slow growth rate while exhibiting immense opportunities for expansion.
Competitive Dashboard:
Some of the key players profiled in the report are Zoetis Animal Healthcare (U.S.), Merck and Co., Inc. (U.S.), Ceva Animal Healthcare (U.K), Virbac Animal Healthcare (France), Merial (France), Elanco Animal Health (U.S.), Bayer Animal Health (Germany), Vetoquinol S.A. (France), Perrigo Company plc (Ireland), and Boehringer Ingelheim (Germany).
Industry Developments:
In April 2018, Lancaster witnessed its first mobile veterinaryunit, SS Pantry, for vaccines and spay/neuter clinics.
In August 2018, FDA has approved NexGard® (afoxolaner), which prevents the infection that causes Lyme disease in dogs.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/companion-animal-healthcare-market-1168
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
AkashAnand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Breast Feeding Accessories Market Is Estimated to Grow at 7.8% CAGR By 2024 | Market Research Future
Breast Feeding Accessories Market Research Report: Information by Product (Breast Pumps, Breast Milk Bottles, Nipple Care Products, Breast Shells, Breast feeding Pillow and Cleaning Products), End User (Hospitals & Clinics and Personal) and Region - Global Forecast till 2027
Breast Feeding Accessories Market Highlights
The global breastfeeding accessories market size is projected to grow at a 7.8% CAGR between 2018-2024, reveals the new Market Research Future’s breastfeeding accessories market report. Breastfeeding accessories comprise of along list of items such as breast shells, cleaning products, nipple care products, nursing pads, breastfeeding pillow, nursing clothes, breast pumps, breast milk bottles, and others that help to make breastfeeding simpler. These essential supplies, along with helping the mother to remain in the flow, will also at the same time keep her and her baby comfortable and happy.
Numerous factors are adding to the global breastfeeding accessories or breastfeeding device market growth. Such factors, according to the recent MRFR report, include favorable breastfeeding promoting policies, improving healthcare infrastructure, decrease in infant mortality rate, rise in female employment rate, and increasing awareness about these accessories.
On the contrary, the high price of products may limit the global breastfeeding accessories market growth over the forecast period.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/8010
Market Segmentation
The Market Research Future Report provides an inclusive segmental analysis of the global breastfeeding accessories market based on end user and product.
By product, the breastfeeding accessories market is segmented into breast shells, cleaning products, nipple care products, nursing pads, breastfeeding pillow, nursing clothes, breast pumps, breast milk bottles, and others. Breast pumps are again segmented into electric and manual breast pumps. Nursing pads are again segmented into reusable and disposables. Breast shell is a vital breastfeeding product for women having leaky breasts, sore nipples, or inverted nipples. Breast cleaning products are used to clean the breast after feeding. Nipple care products are available in different types to provide care to cracked/sore nipples. Nursing pads help in absorbing the surplus milk, thereby protecting the mother’s clothing from stains and wetness. Breastfeeding pillow helps the mother to hold the little one in different positions, thus making it comfortable for both. Besides breastfeeding, these pillows can also be used to offer some soft cushioning, assist with tummy time, and prop babies up. Nursing clothes are designed for the mother’s comfort both at the time of pregnancy and after. A breast pump helps in emulating a nursing baby via mimicking the natural suckling pattern. A breast milk bottle is immensely handy as it helps to collect, store, and feed breast milk.
By end user, the breastfeeding accessories market is segmented into personal and hospital & clinics.
Regional Analysis
By region, the global breastfeeding accessories market covers the growth opportunities and recent trends across Europe, the Americas, the Middle East & Africa (MEA), and the Asia Pacific (APAC). Of these, the Americas will have the lions share in the market over the forecast period. Factors adding to the breastfeeding accessories market growth in the region include favorable breastfeeding promotion policies, demand for innovative breastfeeding accessories, and developing healthcare infrastructure. Besides, the presence of several milk banks and growing awareness about these accessories are also adding market growth.
The breastfeeding accessories market in Europe is predicted to hold the second-largest share over the forecast period. Factors adding to the breastfeeding accessories market growth in the region include the increasing number of milk banks and hospitals for children, increasing support from the government to improve children’s health, and rising woman employment.
The breastfeeding accessories market in the APAC region will grow at a quick pace over the forecast period for increasing birth rate that automatically boosts the need for such accessories, increasing healthcare expenditure by the government, and presence of several developing economies in the region such as India, Australia, and China.
The breastfeeding accessories market in the MEA will have a small share over the forecast period for lack of healthcare infrastructure, low awareness, and poor economies.
Key Players
Notable players profiled in the breastfeeding accessories market report include TommeeTippee/Mayborn Group Limited (UK), NNUK USA LLC (US), Medline Industries, Inc. (US), Handi-Craft Company (US), Artsana S.p.A. (UK), Nuby (USA), Pigeon Corporation (Japan), Ameda (US), Medela LLC (US), and Koninklijke Philips N.V. (UK).
Industry News
February 2020: The Wing and Medela have joined hands to assist co-working females in attaining their breast milk feeding goals.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/breast-feeding-accessories-market-8010
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
AkashAnand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Global HbA1c Testing Market Insights, Growth Outlook, Segmentation and Investment | Forecast to 2027
Global HbA1c Testing Market: Information by Product (Instruments (Bench-Top Device and Handheld Device) and Reagents and Kits), By Technology (Ion-Exchange High-Performance Liquid Chromatography (HPLC), Turbidimetric Inhibition Immunoassay (TINIA), Enzymatic Assay and Others), By End User (Hospitals and Clinics, Diagnostic Laboratories and Others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027
Global HbA1c Testing Market Highlights
The HbA1c testing market is projected to grow at a CAGR of 12.24% during the forecast period. As per the HbA1c testing market research report, the global market for HbA1c testing is projected to grow swiftly by US$1,992.44 Million by 2025. According to analysts, developing healthcare infrastructure as well as growing adoption of advanced diagnostic tools will drive the market growth during the forecast period. The HbA1c testing market research report offers a comprehensive analysis of the global HbA1c testing market and its end user, technology, and product segments. The limited access to healthcare along with lack of awareness are the elements that could influence the HbA1c testing market advancement throughout the forecast period. The HbA1c testing market research report by expert analysts is developed to assist organizations in the HbA1c testing market.
Market Segmentation
The global HbA1c testing market has been segmented based on end user, technology, and product. On the basis of technology, the market for HbA1c testing is segmented based on enzymatic assay, turbidimetric inhibition immunoassay (TINIA), ion-exchange high-performance liquid chromatography (HPLC), and others. Additionally, the market on the basis of product, is segmented into instruments (handheld device and bench-top device), reagents and kits. The global market for HbA1c testing is also covered based on the end user segment which is further split into diagnostic laboratories, hospitals and clinics, and others.
Major elements such as weak healthcare system could obstruct the HbA1c testing market growth. However, according to the HbA1c testing market research report, growing activities such as research and awareness campaigns along with strategic activities such as partnerships and agreements will propel growth throughout the forecast period. The HbA1c testing market is set to register growth at a high CAGR owing to these key factors. The exploration of end user, technology, and product segments along with regional markets has been given in the global HbA1c testing market research report. The research analysts studying the HbA1c testing market have put out market forecasts in the HbA1c testing market research report in order to support HbA1c testing market-based companies. The HbA1c testing market research report provides an extensive understanding of the HbA1c testing market based on the information and forecasts till 2025.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/8517
Regional Overview
North America, Europe, Asia Pacific and the rest of the world regional market for HbA1c testing are predominantly covered in the global HbA1c testing market research report. Country-level HbA1c testing markets spread across North America – the United States, Canada, and Mexico are also covered in the report. In South America – Brazil and other country-level HbA1c testing markets are covered in the report. In Asia-Pacific (APAC) region, the country-level HbA1c testing markets covered are Japan, India, China, and others. The HbA1c testing market research report also explores the regional market for HbA1c testing present in Europe in the United Kingdom, France, Italy, Spain, and Germany, etc. The HbA1c testing market research report also covers regional markets from the rest of the world alongside HbA1c testing markets of Africa and the Middle East.
Competitive Landscape
New advanced treatment options are presumed to drive the HbA1c testing market growth worldwide. The global HbA1c testing market could be challenged by lack of professional expertise, nevertheless, organizations in the HbA1c testing market will carry the growth rate forward. The HbA1c testing market research report presents company profiles of major companies active in the HbA1c testing market globally. Furthermore, the global HbA1c testing market report offers an all-inclusive analysis of the market collected from the HbA1c testing market’s primary and secondary sources covering both decision makers and thought leaders. The HbA1c testing market research report highlights such key areas assisting businesses operating in the HbA1c testing market to build better growth strategies.
Industry News
The Phase II volagidemab trials in REMD Biotherapeutics have demonstrated glycemic regulation improvements. The findings showed that, after 12 weeks of care in Type 1 patients with Diabetes T1D, volagidemab was associated with substantial glycemic control improvements assessed by haemoglobin A1c (HbA1c) and CGM parameters. Although full results have not been announced yet, the phase I study showed that patients could reduce their daily use of insulin by 26% (12 units).
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/hba1c-testing-market-8517
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Advanced Wound Therapy Devices Market Insights, Growth Outlook, Segmentation and Investment | Forecast to 2027
Advanced Wound Therapy Devices Market Research Report: by Type (Negative Pressure Wound Therapy Systems, Electric Stimulation Devices, Hyperbaric Oxygen Equipment, Pressure Relief Devices, Others), by End-user (Hospitals & Clinics, Home Care Settings, Others), and Region - Global Forecast till 2027
Advanced Wound Therapy Devices Market Highlights
Market Research Future (MRFR) predicts that the global advanced wound therapy devices market to touch the valuation of USD 2,804.53 million by 2023. It could demonstrate a CAGR of 6.70% CAGR during the forecast period (2018-2023).
Market Drivers and Top Barriers
Advanced wound care sector is emerging rapidly, as it provides devices as well as solutions that help manage acute and chronic wounds. Advanced wound therapy devices are used for treating wounds that take place due to pressure venous disease, ulcers, diabetes, and others.
Rising cases of diabetes is one the most important growth-inducing factors in the market. Those with diabetes heal at a slow rate and have poor blood circulation that negatively affects the immunity system. The Centers for Disease Control & Prevention (CDC) reveals that close to 30.3 million in the United States (U.S.) have diabetes. Trade pundits predict that the worldwide advanced wound therapy devices market could capitalize on this trend by offering precise solutions, thereby expanding in the subsequent years.
The burgeoning geriatric population is benefitting the market to a great extent. This factor is supported by facts presented by the World Health Organization (WHO), that says the elderly populace could reach around 1.2 billion by 2025. Moreover, emergence of novel products along with rapid approval by regulatory bodies benefits the advanced wound therapy devices market. To illustrate, ConvaTec was approved by FDA for its negative pressure wound therapy (NPWT) system in 2018.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/7421
Market Segmentation
The worldwide advanced wound therapy devices market has been considered for type and end-user.
Types of therapy devices mentioned in the report are hyperbaric oxygen equipment, electric stimulation devices, negative pressure wound therapy systems, pressure relief devices, and others. The negative pressure wound therapy systems controlled close to 42.9% share in 2017, with pressure relief devices coming second with a 28.2% share. Hyperbaric oxygen equipment accounted for 15.2%, electric stimulation devices for 7.9%, and others came to 5.8% of the total market. Negative pressure wound therapy systems could expect to reach the valuation of USD 1,217.41 million by 2023, surging at a rate of 6.91% during the forecast period. On the other hand, pressure relief devices are expected to achieve the highest CAGR of 7.03% in the next few years, with it predicted to touch around USD 805.35 million by 2023.
End-users enlisted in the report cover home care settings, hospitals & clinics, and others. Hospitals & clinics was at the top with a 73.7% share in 2017, with home care settings at the second position with a 14.5% share and others accounting to 11.8%. Hospitals & clinics can obtain a CAGR of 6.95% during the forecast period, to arrive at the valuation of USD 2,095.66 million by 2023. Furthermore, the home care settings segment could exhibit a CAGR of 6.78% to expand at USD 408.50 million by the end of the appraisal period.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/advanced-wound-therapy-devices-market-7421
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Cancer Biomarker Market To Project 15.8% CAGR By 2023
Global Cancer Biomarker Market Research Report: By Types (Protein Biomarker, Genetic Biomarker), By Applications (Diagnostic, Prognostic, Therapeutic), By End Users (Pharmaceutical and Biotechnology Companies, Diagnostic Companies) – Forecast till 2027
Cancer Biomarker Market Highlights
Cancer biomarkers biochemical entities that are released during the presence of a tumor, indicating the presence of cancer in the body. Targeting biomarkers in cancer treatment are becoming a standard in the era of precision medicine. Market Research Future (MRFR) has thoroughly studied the trends and patterns in the global cancer biomarker market over the forecast period of 2017-2023 in a detailed study. MRFR asserted that the cancer biomarker is likely to strike a CAGR of 15.8% over the forecast period.
The increasing burden of oncological disorders has resulted in the move towards early detection and preventive approach towards cancer. Extensive research is being carried out to further understand the role of biomarkers and come up with new biomarkers to predict treatment effectiveness and treatment activity in various oncology disorders. This coupled with massive investment by both public, and private entities have augmented the growth of the cancer biomarker market. The growing popularity of personalized medicine is a key factor in enhancing the growth of the cancer biomarker market. Personalized medicine hinges on biomarkers in extracting information that is relevant for diagnosis, prognosis, and therapy and is core to the personalized medicine field. Biomarker-driven approach can accelerate the drug development process in cancer, and various pharmaceutical companies are outlaying massive investments in R&D activities which are expected to augment the growth of the market over the forecast period. Furthermore, cancer biomarkers are an area of active research of the US FDA. Recent years have witnessed the approval of various cancer biomarkers and has paved the way for the expansion of the cancer biomarker market.
On the contrary, low benefit-cost ratio associated with the development of cancer biomarkers is likely to restrain the growth of the global cancer biomarker market.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/5378
Segmentation
The global cancer biomarker market has been segmented based on type, application, and end user.
By type, the cancer biomarker market has been segmented into protein biomarker, genetic biomarker, and others.
By application, the cancer biomarker market has been segmented into diagnostic, prognostic and therapeutic. The diagnostic segment has been further segmented into imaging and non- Imaging.
By end user, the cancer biomarker market has been segmented into pharmaceutical and biotechnology companies, diagnostic tool companies, healthcare it/big data companies, clinical laboratories
Regional Analysis
By region, the cancer biomarker market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
The Americas account for the largest share of the cancer biomarker market. The high incidence rate of cancer and rapid advances in the cancer biomarker arena to come up with new drugs and effective therapies is supporting the growth of the market.
The Europe market is driven by rigorous clinical trials and government funding for the same.
The influx of investment for R&D by both public and private sector is driving the growth of the APAC cancer biomarker market. In addition, increasing prevalence of cancer has evoked extensive R&D activities for the development of new therapies and drugs.
MRFR projects relatively slow growth in the MEA cancer biomarker market. Low penetration of advanced diagnostics and treatment facilities and lack of awareness hinders the growth of the market.
Competitive Landscape
F. Hoffmann-La Roche AG (Switzerland), PerkinElmer, Inc. (U.S.), Bristol-Myers Squibb (U.S.), Novartis AG (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories (U.S.), Merck & Co., Inc. (U.S.), Becton Dickinson (U.S.), Abbott Laboratories (U.S.), Pfizer Inc. (U.S.), QIAGEN N.V (U.S.), GlaxoSmithKline Plc. (U.S.), Illumina Inc. (U.S.), and Eli Lilly and Company (U.S.) are the distinguished players in the cancer biomarker market.
Industry Updates
April 2019 - Scientists at the University of Southern California, US, are researching the presence of polymorphisms, specific genes known for detecting the presence of cancerous cells. The success of these findings can culminate in the use of these markers for detecting colorectal cancer at a preventive stage.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/cancer-biomarker-market-5378
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Healthcare RFID Market Is Estimated to Grow at 23.37% CAGR By 2023 | Market Research Future
Healthcare RFID Market: Information By Component (Tags, Readers, Middleware, Printers), Application (Equipment Tracking, Medicine Tracking, Others), End-User (Pharmaceutical and Biotechnology Companies, Hospitals, Others) — Global Forecast till 2027
Healthcare RFID Market Highlights
The healthcare radiofrequency identification (RFID) market was evaluated at USD 1,154 million in 2017 and can achieve a CAGR of 23.37% during the forecast period (2018-2023), states Market Research Future (MRFR).
Growth Boosters and Top Barriers
The fundamental reasons backing market growth could be the increasing focus on the reduction of operational costs and streamlining the workflow. Other than this, rising demand for an organized supply chain management and the need for enhancing the quality and efficiency of care also favor the market.
High operational costs in the healthcare industry boost the adoption of RFID technology within healthcare organizations. Medical device manufacturers, pharmaceutical companies, hospitals, and various other healthcare organizations extensively use this technology to curb inventory costs. RFID technology allows organizations to efficiently manage inventory and also helps prevent stock out and overstock situations. RFID tags aid the surgical staff to easily track medical devices used in operation theatres, which enhances patient safety. Growing need to reduce operating costs fuel the adoption rate of RFID. This technology also finds use in blood banks, pathology labs and laboratories for better workflow management and efficient product tracking.
RFID technology gives rise to sufficient patient monitoring, better communication, patient identification, as well as patient tracking. This helps in bringing down medication errors and elevate safety. Thus, the growing need for patient monitoring and mandates to elevate safety contribute to market growth.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/7580
Market Segmentation
The global market for healthcare RFID has been segmented on the basis of components, applications, and end-user.
Components-based segments in the market are tags, readers, middleware, printers, and others.
The applications of healthcare RFID are people identification and tracking, equipment tracking, medicine tracking, medical report and blood samples tracking, and others.
The end-users covered in the report include pharmaceutical and biotechnology companies, hospitals, research institutes, and others. The tags segment expects to cover the maximum share in the market, based on its wide application in pharmaceutical tracking and asset tracking. Meanwhile, the growth of the user research institutes segment could be the highest in the market, on account of the surge in research and development by significant vendors in the upcoming years.
Regional Analysis
The primary markets for healthcare RFID are Europe, Asia Pacific, Middle East & Africa, and the Americas.
Americas could expect to reign over other regions in the global healthcare RFID market, due to increasing strategic alliance by well-established companies and the rising number of non-profit organizations giving a hand in research & development. On top of this, highly developed healthcare infrastructure in the region further stimulates the market growth. The US Department of Health and Human Services reports that in 2018, at least 1,735,350 cases of cancer were diagnosed in the country, which could lead to around 609,640 deaths.
Europe can expect to be the second-most lucrative healthcare RFID market. The regional market profits from favorable government support in the form of funding as well as the support of the healthcare sector. Furthermore, increasing research and development in the region paves the way for further market expansion in the near future.
Expanding at the fastest rate in the healthcare RFID market, Asia Pacific can expect strong growth backed by rising investments in healthcare and improving healthcare infrastructure. The market growth in India and China is believed to be the fastest, based on the rising focus on adopting new technology by the government, along with the availability of advanced treatment options. The World Health Organization noted that in 2010, India’s healthcare expenditure was about 3.27% of GDP, which increased to 3.89% in 2015.
Middle East & Africa could be the smallest healthcare RFID market in the coming years, owing to the substandard healthcare sector, dearth in technical knowledge, and poor medical facilities.
Key Companies
The companies currently leading the worldwide healthcare RFID market include Mobile Aspects, Inc., CAEN RFID S.r.l., Gao RFID, Inc., Honeywell International Inc., RF Technologies, Invengo Information Technology Ltd. Co., STiD RFID, Applied Wireless Identifications Group, Inc., Motorola Solutions, Inc., Radianse, Impinj Inc., Stanley Healthcare, Alien Technology Corporation, to name a few.
Industry Update
June 2019
Reports suggest that after the use of an RFID-backed cabinet system that manages catheter labs as well as medical supplies, Sheba Medical Center has managed to cut costs. With RFID, the hospital gets real-time data regarding which medical supplies are in stock and which are being used for procedures, among other things.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/healthcare-rfid-market-7580
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Digital Therapeutics Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2018-2023
Digital Therapeutics Market Research Analysis By Product Type (Software, Devices And Others), Application (Cardiovascular Diseases, Obesity, Diabetes, Respiratory Diseases, Smoking Cessation and Others) and Sales Channel (B2B and B2C) and End Users - Global Forecast 2027
Digital Therapeutics Market Highlights
The global digital therapeutics market size is anticipated to grow at a favorable CAGR between 2018-2023, as per the latest MRFR’s digital therapeutics statistics. Digital therapeutics offer patients with therapeutic interventions that are evidence-based and are driven by superior quality software programs for preventing, managing, or treating a disease or medical disorder. They are used together with other therapies, devices or medications, or independently for optimizing health outcomes and patient care.
Various factors are propelling the digital therapeutics market growth. Such factors, according to the latest Market Research Future report, include an increased requirement for reduced healthcare spending coupled with improved therapeutic outcomes, favorable initiatives undertaken by the government to reinforce the development as well as the implementation of various digital therapeutic solutions, technological advancements, growing geriatric population, and increasing prevalence of chronic diseases. Additional factors propelling the growth of the digital therapeutics market include rising penetration of tablets and smartphones and rising awareness about its different benefits such as improved doctor and patient communication, managing patient’s health supplements effectively, and low healthcare expenditure.
On the contrary, concerns about patient data privacy, lack of awareness about digital therapeutics, resistance from traditional practitioners, reluctance among patients for adopting digital therapeutics, lack of digital therapeutics reimbursement, and strict regulatory needs are factors that may restrict the digital therapeutics growth during the forecast period.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/6492
Market Segmentation
The Market Research Future report offers a complete segmental analysis of the digital therapeutics market based on sales channel, type, and application.
By product, the digital therapeutics market is segmented into devices and software. Of these, the software segment will lead the market during the forecast period. The software includes various health-related platforms and apps, thus comprises the base of digital therapeutics. It helps to transmit a patient’s data to physicians from wearable devices through various electronic devices, namely tablets and mobiles.
By application, the digital therapeutics market is segmented into smoking cessation, respiratory diseases, diabetes, obesity, cardiovascular diseases, and others. Of these, the obesity segment will dominate the market during the forecast period. An increase in the
obese population and a sedentary lifestyle that increases the risk of type-2 diabetes, hypertension, and stroke are adding to the market growth.
By the sales channel, the digital therapeutics market is segmented into B2C and B2B. Of these, the B2B segment will have the maximum share in the market during the forecast period.
Regional Analysis
By region, the digital therapeutics market report covers the latest trends and growth opportunities across the Asia Pacific, North America, Europe, and the Rest of the World. Of these, North America will have the lion’s share in the market during the forecast period. Various factors propelling the growth of the digital therapeutics market in the region include expansion of healthcare sectors, the inclusion of the next-generation healthcare technology, rising investments in research and developments, rising prevention of chronic diseases, and early adoption of technology. The US is the major contributor in the market. Increasing incidence of chronic diseases, rising investments in the field of digital therapeutics, and improving reimbursement structure are the key factors boosting the growth of the US digital therapeutics market.
The digital therapeutics market in Europe will have the second-largest share during the forecast period. Various factors propelling the growth of the digital therapeutics market in the region include the growing demand in the region for digitalization of healthcare coupled with widespread awareness about the advantages of digital therapeutics.
The digital therapeutics market in the APAC region will grow at the fastest pace during the forecast period. Various factors propelling the growth of the digital therapeutics market in the region include increasing government initiatives, rising use of smartphones, and improved healthcare infrastructure. India is a major contributor in the region. Rising geriatric population is generating huge demand for digital therapeutics in India, especially digital health applications, namely AI, mHealth, chatbots, and telemedicine.
The digital therapeutics market in the Rest of the World will have steady growth during the forecast period.
Key Players
Notable players profiled in the digital therapeutics market report include Livongo Health, Omada Health, Inc., WellDoc Inc., Noom Inc, Medtronic Plc., Canary Health Inc., Propeller Health, Mango Health, Inc., Proteus Digital Health, Inc., and Twine Health Inc.
Industry News
November 2019: Astellas Pharma Inc. and Welldoc, Inc. have entered into a license agreement and collaboration for the development as well as commercialization of digital therapeutics.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/digital-therapeutics-market-6492
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Global Medical Cannabis Market: Development History, Current Analysis and Estimated Forecast to 2027
Global Medical Cannabis Market Research Report: By Product form (Powders, Solids, Ointments and creams, Oil, Others), By Derivative (Cannabidiol, Tetrahydrocannabinol), By Application (Arthritis, Cancer, Alzheimer’s disease, others) and By Distribution Channel (Retail pharmacy, Online stores, others) – Forecast to 2027
Global Medical Cannabis Market Highlights
The global market report covering the Medical Cannabis market revealed an opportunity for the market to score a valuation of USD 52.35 Billion by 2025. This would happen with a CAGR of 15.4% CAGR between 2019 and 2025, which as per Market Research Future (MRFR) is the forecast period. Increasing instances of chronic diseases and other severe medical conditions can inspire better market growth in the coming years. Chronic diseases like schizophrenia, cancer, arthritis, Alzheimer’s disease, and others have created a demand for the substance owing to its medicinal properties. There are several private companies who are investing much to make sure that the market gets prominence. In fact, government participation is also inspiring for better growth opportunities. The growth of the market for medical cannabis can also inspire illegal practitioners taking advantage of the system, which can hold back the smooth growth in the coming years.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/8368
Segmentation
The global market report on medical cannabis includes studies on the application, derivative, product form, and distribution channel. Various product dynamics are expected to make changes in the understanding of the market. Also, this segmentation would reveal strong potentials for the market and the insights would assist players in having better growth.
By product form, the global market report covers the medical cannabis market by having it segmented into solids, oil, ointments & creams, powders, and others. The powder segment covers most of the market area, however, the solid segment is showing ample opportunities to emerge as the fastest market player. The ‘others’ segment includes tinctures, lozenges, and smoking dried buds.
By derivative, the market report providing insights on the medical cannabis market includes cannabidiol (CBD) and Tetrahydrocannabinol (THC). The cannabidiol segment would gain better growth opportunities due to its wide-spread applications.
By application, the market for medical cannabis comprises cancer, Schizophrenia, Alzheimer’s disease, arthritis, and others. Alzheimer’s disease has the largest segment, whereas, the cancer segment can produce a high growth rate in the coming years.
By distribution channel, the report on the global market for medical cannabis covers online stores, retail pharmacies, and others. The retail segment fetches the maximum market share but the online segment can outdo others in terms of market growth.
Regional Analysis:
The global market for medical cannabis covers on a region-specific scale places like the Americas, the Asia Pacific region, and Europe as regions with the maximum potential to fetch high revenues. However, the discussion also includes the Middle East & Africa (MEA) as a possible moderate growth-provider.
The Americas can be branded as the largest market as in North America, two countries the US and Canada are setting up huge research and development sectors to maximize profit. The intent is to develop drugs to pacify the mal-effects of various diseases. Effective law, hike in investment probability, better research facilities are a few of the factors included in a detailed study of the regional growth demographics. In Europe, similar growth is possible for the regional market with several players impacting the intake capacity. The Asia Pacific market is also opening up to the market and countries here have realized the potential of the research area with a proper exploration of the properties of cannabis.
Competitive Landscape:
Several market players have recorded tactical changes using which they can inspire growth in the medical cannabis market. MRFR’s list shows some of them with their recent profiles to facilitate understanding. These companies are Tilray (Canada), Aurora Cannabis (Canada), Maricann Inc. (Canada), Aphria, Inc. (Canada), Canopy Growth Corporation (Canada), GW Pharmaceuticals PLC (UK), Medical Marijuana, Inc. (US), Cannabis Sativa Inc. (US), United Cannabis (US), CanniMed Ltd (Canada), MediPharm Labs (Canada), GBSciences Inc. (US), and others
In November 2019, two new medicines got approved by NHS for the treatment of diseases like epilepsy and multiple sclerosis. These two medicines only got clearance for the UK as a beginning.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/medical-cannabis-market-8368
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Medical Document Management Systems Market Size, Share By 2023 | Technology Development, Global Industry Analysis, Demand Overview, Insights, Growth, Top Company Profile
Global Medical Document Management Systems Market Research Report: By Products (Services, Solutions), By Application (Medical Records, Billing Records, Admission & Registration, Others), By Delivery Model (Web-based, Cloud-based, On-premise) and By End-user (Hospitals & Clinics, Healthcare Providers, Nursing Homes, Insurance Agencies) – Forecast to 2023
Medical Document Management Systems Market Highlights
Medical document management systems are software with the capacity of storing, management, and retaining of patient documents. The changes in the healthcare sector, investments in healthcare IT, and inflow of patients are factors discussed in detail in the global medical document management systems market report by Market Research Future (MRFR). The COVID-19 pandemic and its impact on the market are explored as well.
Market Scope
The global medical document management systems market size is touted to expand at a momentous growth rate owing to the increasing volume of data to be acquired in the coming years. The large influx of patients, shift to electronic health records, and the prevalence of various diseases are all main factors driving market growth. Maintenance, continuous updates, and a bid to curb rising healthcare costs can fuel the market demand in the coming years.
Supportive government policies encouraging its use in the healthcare sector and a surge in interest has led to investments and fundraising in the industry. The motive to lower human errors in billing, regulatory compliance, and a sharp dip in reimbursement premiums can bode well for the market.
But lack of infrastructure, skilled personnel, and funds can hamper the market growth.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/6578
Segmentation
The global medical document management systems market has been segmented by product, application, delivery model, and end-user.
By product, it is divided into services and solutions. Solutions are expected
By application, it is segmented into admission & registration, billing records, medical records, and others. Medical records are predicted to garner huge revenues owing to its ability to being assist in diagnosis and preventive care of patients.
By delivery model, it is segmented into on-premise, cloud-based, and web-based.
By end-user, it is segmented into insurance agencies, healthcare providers, hospitals & clinics, and nursing homes. The healthcare providers segment is expected to be one of the biggest end-users of the global medical document management systems market owing to its need to lower data entry errors. The lowering of revenue losses due to medical billing errors can support the segment growth over the forecast period.
Regional Analysis
Asia Pacific (APAC), Europe, North America, and Rest-of-the-World (RW) are regions covered with respect to the prospects of the global medical document management systems market.
North America is projected to be highly lucrative for the market owing to establishment of healthcare facilities, modernization of infrastructure, and shift to digital modes of record-keeping and maintenance. Healthcare insurance programs for the public such as Medicaid and Medicare, new coding standards for the medical industry, and insights gleaned from consumer data can drive the global medical document management systems market demand. Integration of analytics software to improve patient outcomes can fuel its demand.
APAC is touted to showcase a phenomenal growth rate during the forecast period due to a large patient pool and need for technology to lower the burden on healthcare staff. The boom in medical tourism, switch to electronic medical records, and subsidies for public welfare are incentives likely to work in favor of the market.
Competition Outlook
Kofax Ltd., Toshiba Corporation, EPIC Systems Corporation, 3M Company, McKesson Corporation, Nextgen Healthcare Information Systems, LLC, Allscripts Healthcare Solutions Inc., Athena Health Inc., Hyland Software Inc., Siemens Medical Solutions USA Inc., GE Healthcare, and Cerner Corporation are prominent names in the global medical document management systems market.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/medical-document-management-systems-market-6578
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes